Achieve Life Sciences, Inc. (QUIT)
NASDAQ: QUIT · Real-Time Price · USD
6.29
-0.16 (-2.48%)
At close: Nov 12, 2026, 4:00 PM EST
6.29
0.00 (0.00%)
After-hours: Nov 12, 2026, 4:15 PM EST

Achieve Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-64.12-54.88-39.07-27.25-40.8-33.09
Net Income
-111.71-54.65-39.83-29.82-42.35-33.15
Earnings Per Share
-1.46-1.25-1.24-1.50-4.00-4.08
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
201.5236.434.3615.5524.7743.02
Total Debt
14.0514.969.9616.7316.214.99
Net Cash (Debt)
187.4721.4524.4-1.198.5728.03
Net Cash Growth
391.33%-12.10%---69.41%-21.62%
Net Cash Per Share
2.440.490.76-0.060.813.45

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-44.04-49.47-29.77-24.48-37.57-29.44
Capital Expenditures
-0.05-0--0.02--
Free Cash Flow
-44.1-49.47-29.77-24.5-37.57-29.44
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.